MEET OUR SEASONED GOVERNANCE TEAM  

Stephen J. Fanning was appointed President and Chief Executive Officer of Solta Medical, Inc. (formerly Thermage, Inc.), a leader in non-invasive tissue tightening in the aesthetic industry, on January 15, 2005. He was elected Chairman of the Board of Directors effective as of July 31, 2006. Under his leadership, the Company went public in November 2006, raising $42 million. Also, in January 2009, he led the successful integration of the acquisition of Reliant Technologies, Inc., which combined the industry’s two leading brands, Thermage® and Fraxel®, under a new corporate name of Solta Medical Inc., forming a global leader in aesthetic energy devices. In February 2010, he also led another successful integration of the acquisition of Aesthera Corporation bringing together the Isolaz™ brand of products for the treatment of acne with Solta’s leading brands for skin tightening and skin resurfacing. Mr. Fanning has an extensive background in the healthcare, consumer pharmaceuticals and consumer package goods industries.

Mr. Fanning joined Thermage, Inc. from Ocular Sciences, Inc., a $350 million global public company, which developed, manufactured and marketed disposable contact lenses. Mr. Fanning had been President and Chief Executive Officer of the Company and a member of the Board of Directors since August 13, 2001. Under his leadership, Ocular Sciences implemented a next-generation manufacturing process significantly driving down the cost of goods sold, achieved significant increases in global market share and attained more than $300 million in annual sales. In January 2005, Ocular Sciences was successfully acquired by CooperVision for $1.3 billion.

Mr. Fanning joined Ocular Sciences from Johnson & Johnson (J&J), one of the world’s largest manufacturers of healthcare products, where he served in various senior executive positions of escalating responsibility for 25 years. His most recent position was President, Worldwide, of J&J’s McNeil Specialty Products division. Prior to that, he served as President of Johnson & Johnson Medical, a medical device company. Mr. Fanning has also served as Managing Director of J&J Austria/Switzerland, and Vice President, Sales, of J&J’s McNeil Consumer Products Division.

Mr. Fanning holds a Bachelor of Science degree from Philadelphia University.

Mr. Covert was nominated to our Board of Directors effective July 11, 2007 and serves as Chairman of our Audit Committee. In October 2007, Mr. Covert was appointed Chief Financial Officer of Silicon Image, a leader in the secure distribution, presentation and storage of high-definition content. From October 2005 to October 2007, Mr. Covert served as Chief Financial Officer of Openwave Systems, a provider of software solutions for the communications and media industries. From December 2003 to September 2005, Mr. Covert served as Chief Financial Officer of Fortinet, a security software company. From July 2001 to October 2003, Mr. Covert served as Chief Financial Officer of Extreme Networks, a network infrastructure equipment provider. Mr. Covert currently serves as a director of JDS Uniphase, a networking equipment manufacturer. Mr. Covert received his B.S. degree from Lake Erie College and his M.B.A. from Cleveland State University. Mr. Covert is a Certified Public Accountant.

Len has more than 30 years of experience in lasers, laser scanners, medical systems and senior management within the laser industry, and he has been the driving force behind the breakthrough technology in the Fraxel® family of lasers. Beginning in 2001, he has provided leadership to the company as President, Chief Technology Officer and CEO. In his present role, Mr. DeBenedictis directs the development of Reliant's new technology, products and applications.

Before joining Reliant, Mr. DeBenedictis spent 11 years with Coherent Inc. in a variety of positions, ultimately becoming General Manager of the Medical Group. At Coherent, Mr. DeBenedictis turned a poorly performing division into a profitable one with annual sales exceeding $100 million. During that period, Coherent Medical introduced the UltraPulse CO2 laser, the most rapidly adopted aesthetic laser product until the release of the Fraxel laser. Many of Coherent's leading engineers and executives have joined Mr. DeBenedictis at Reliant Technologies, a testament to their belief in his vision and leadership abilities.

Prior to Coherent, Mr. DeBenedictis was the Engineering Manager for the Construction Systems Division of Spectra Physics, Inc.; Director of Operations and Engineering at ARCO Ventures; and Manager of Laser Scanning Technology for Xerox. While leading the Laser Scanning Technology Center for Xerox, Mr. DeBenedictis developed the insights that have fueled the patented technology underlying the Fraxel laser.

Mr. DeBenedictis's industry experience goes back to 1965 when he was an early contributor at Korad Lasers, the first commercial laser company. Mr. DeBenedictis reported to Dr. Walter Koechner, whose work and classical texts in solid-state lasers continue to be the reference of choice for the industry. Korad was founded by Theodore Maiman, who demonstrated the first lasing action in solid-state materials and built the first Ruby laser systems that were used in ophthalmology.

Mr. DeBenedictis is a well-respected executive and a highly regarded scientist. Working closely with Dr. R. Rox Anderson at the Wellman Institute for Photomedicine, Mr. DeBenedictis led the development of the system technology, scanner technology, biomedical and clinical studies upon which the Fraxel laser was built. As a senior executive and technical leader, he continues to shape the vision for Reliant Technologies.

Dr. Knowlton is the original founder of Thermage. His many accomplishments include the invention of the ThermaCool TC System. Dr. Knowlton is also an active Plastic Surgeon with 26 years of experience in private practice. He is the founder of the Danville Ambulatory Surgery Center, an outpatient Plastic Surgery Center of Excellence that was established in 1983. Dr. Knowlton graduated from the Washington University Medical School in St. Louis in 1973, completed his surgical residency in 1978, and was certified by the American Board of Plastic Surgery in 1981. He is the author of numerous patents in the medical device field and has written several scientific papers on Plastic Surgery including an innovative approach to breast reconstruction called the Peg Procedures.

Ms. McCarthy was nominated to our Board of Directors effective July 11, 2007 and serves on our Audit and Compensation Committees. Ms. McCarthy is President & Chief Executive Officer of SM&A, a provider of business capture and post-award risk mitigation services. Since 2000, Ms. McCarthy has served in various senior executive positions at SM&A, including Executive Vice President, Chief Financial Officer, Corporate Secretary and from 2005 to the mid-2007, Ms. McCarthy served as its President and Chief Operating Officer. Ms. McCarthy currently serves as a director of Operation Homefront, a charitable organization and the Orange County Advisory Board of City National Bank. Ms. McCarthy attended Robert Morris College and the University of Wisconsin at Madison.

Ms. Morfitt was nominated to our Board of Directors effective July 11, 2007 and serves as Chairman of our Nominating & Governing Committee. She is the President and Chief Executive Officer of Airborne, Inc. the maker of dietary supplements. From March 1998 to March 2007, Ms. Morfitt was the President and a Director of CNS, a manufacturer and marketer of consumer healthcare products. From 1998 until June 2001 she served as CNS’ President and Chief Operating Officer, and from June 2001 until March 2007 as its President and Chief Executive Officer. Prior to CNS, Ms. Morfitt spent 16 years with The Pillsbury Company, a consumer food products company. Ms. Morfitt currently serves as a director of Graco, Inc, a manufacturer of fluid handling systems. She also serves as a director of Lululemon Athletica, Inc., maker and retailer of aesthetic apparel and Lifetime Fitness, Inc., the operators of a national chain of health and fitness clubs. Ms. Morfitt received her HBA from the University of Western Ontario and her MBA from York University in Toronto.

Mark M. Sieczkarek is President/CEO of Conceptus, Inc. and a member of the Board of Directors since April 2003. He also serves as Chairman of our Compensation Committee. Mr. Sieczkarek was Senior Vice President and President of The Americas Region, responsible for the commercial operation of all Bausch & Lomb businesses in the United States, Canada and Latin America. Mark joined Bausch & Lomb in 1995 as Vice President and Controller in the former Personal Products division and also served as a Vice President in Corporate Business Development. Previously, Mark held executive level position with KOS Pharmaceuticals, several Bristol Myers-Squibb subsidiaries and Sanofi Diagnostics Pasteur. He received a MBA degree in Finance from Canisus College in Buffalo, NY., and a B.S. degree in Accounting from the State University of New York at Buffalo in 1976.

Eric Stang possesses a wealth of leadership experience from company founder to corporate CEO, with a career including positions in consumer products, semiconductors, scientific computer and medical technology, strategic planning, and general management. Prior to joining Reliant, he was Chief Executive Officer, President, and Chairman of the Board of Directors for Lexar, now a subsidiary of Micron. Lexar is a leading provider of NAND flash memory products, including memory cards, USB flash drives, card readers and ATA controller technology for the digital photography, consumer electronics, industrial and communications markets. During his seven years at Lexar, Mr. Stang played a leadership role in taking the company public, effectively enacted a turnaround strategy, led its growth and entry into new markets, oversaw the development of a consumer brand, and established Lexar products in over 70,000 storefronts worldwide with 2005 revenues in excess of $850 million. Under Mr. Stang’s leadership, Lexar became one of the 50 largest public technology companies in Silicon Valley before its acquisition by Micron.

Prior to Lexar, Mr. Stang was with ADAC Laboratories, where he led the company's worldwide radiation therapy planning business, which at the time was the company’s fastest growing and most profitable division. In this role, Mr. Stang worked closely with luminary oncologists and medical physicists at several universities around the world in support of ADAC's technology leadership in radiation treatment planning. Mr. Stang also served as Vice President and General Manager of ADAC Laboratories.

Previously, he was Director of Operations at Raychem Corporation. Mr. Stang co-founded Monitor Company Europe Limited, an international strategic consulting firm in Europe. He has also worked for McKinsey & Company and as a software engineer at Ford Aerospace (now Loral). He holds a B.A. in economics from Stanford University and an M.B.A. from the Harvard Graduate School of Business at Harvard University. Additionally, Mr. Stang sits on the board of Miradia, a private company that designs and manufactures a micro-mirror array that drives high-performance, high- definition displays.